Endogenex logo

Endogenex Funding & Investors

Plymouth, MN

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels. Established in 2017, Endogenex has developed a novel therapy that utilizes pulsed electric fields to promote regeneration of the duodenal mucosa for improvement in glycemic control in patients with T2D.

endogenex.com

Total Amount Raised: $112,996,352

Endogenex Funding Rounds

  • Series C

    $88,000,000

    Series C Investors

    Sante Ventures
    Hatteras Venture Partners
    Longitude Capital
    Lumira Ventures
    Mayo Clinic
    Orlando Health Ventures
    Intuitive Ventures

  • Series Unknown

    $12,000,000

    Series Unknown Investors

    Intuitive Ventures

  • Series A

    $12,756,355

    Series A Investors

    Sante Ventures

  • Seed

    $100,000

    Seed Investors

    Southeast Minnesota Capital Fund

  • Pre Seed

    $140,000

Funding info provided by Diffbot.